Brief: Creative Medical Technology Announces Peer Reviewed Publication Of Positive Results For Stemspine Study
26/09/2022 13:26
Sept 26 (Reuters) - Creative Medical Technology Holdings
Inc CELZ.O :
* CREATIVE MEDICAL TECHNOLOGY ANNOUNCES PEER REVIEWED
PUBLICATION
OF POSITIVE RESULTS FOR STEMSPINE STUDY
* CREATIVE MEDICAL TECHNOLOGY - 2 YEAR FOLLOW-UP RESULTS
CONFIRM
EFFICACY & NOSERIOUS ADVERSE EFFECTS IN PATIENTS WHO USED
STEMSPINE PROCEDURE
* CREATIVE MEDICAL TECHNOLOGY - STEMSPINE PROCEDURE RESULTED
IN
EFFICACY RATE OF 87% IN TREATED PATIENTS IN TERMS OF DECREASED
PAIN AND INCREASED MOBILITY
Source text for Eikon: ID:nPn16Hsg9a
Further company coverage: CELZ.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Creative Medical Technology Holdings
See all newsBrief: Creative Medical Technology Buys 4 Million Biodefense Shares For $200,000 Cash And 1 Million Shares On Sept 24
Brief: Creative Medical Technology Holdings Successfully Completes Enrollment And Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation And Phase 3 Planning
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM